Supporting Weak Immune System During Autoimmune Therapy: Testing Panzyga to Prevent Infections

Clinical trial NCT07220915 · RECRUITING

Trial details

NCT number: NCT07220915
Sponsor: Octapharma
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Hypogammaglobulinemia Autoimmune Conditions Rheumatic Conditions Infections

Start date: 2026-06-10
Primary completion: 2029-12-01
Enrollment: 360

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.